As shown in the study by Zhang et al. oncostatin M receptor β (OSMR-β) deficiency effectively delays the development of atherosclerosis and improves the stability of vulnerable plaques by suppressing the JAK2/STAT3 signal pathway, thereby reducing the incidence of AMI and ischemic stroke [31]. The gene discussed is STAT3; the disease is ischemic stroke.